Positron Corporation (Positron) operates through Molecular Imaging Devices and Radiopharmaceutical Products. The Molecular Imaging Devices provide positron emission tomography (PET) scanners and single photon emission computed tomography (SPECT) cameras. The Radiopharmaceutical Products offer the robotic systems for distribution and delivery of radiopharmaceuticals and provides radiopharmaceutical agents used for the diagnosis of cardiac diseases. In June 2008, the Company announced that it acquired NukeMed, Inc.’s subsidiary, Dose Shield Corporation and has formed a new subsidiary, Positron Pharmaceuticals Company. Positron designs, manufactures, markets and services advanced molecular imaging devices/software for cardiology utilizing PET technology under the name POSICAM, and SPECT technology under the name Pulse CDC.